Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody

Abstract

The present study indicates that fluorescently labeled anti-EGFR Affibody can provide significantly better delineation of tumor margins than a fluorescently labeled anti-EGFR antibody and shows considerable potential for guiding margin detection during neurosurgery.